Phase II study of imatinib-based chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia.
| Image |  |
|---|---|
| Description | scientific article published on 19 January 2017 |
| Author/s |
author: Shin Fujisawa Keitaro Matsuo |
| Publication date | February 21, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |